Development of a Computer Assisted Survivor Screening For Adult Survivors of Childhood Cancer

Memorial Sloan Kettering Cancer Center (MSK)

Status: Completed

Conditions: Childhood Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT00579293

04-098

Details and patient eligibility

About

This study will compare two ways of having people respond to a questionnaire about health and emotional well-being: on a computer and with paper and pencil. We will see how long it takes using both methods. We will also ask you how you feel about using a computer to answer the questions.

Full description

To determine feasibility of using the Computer Assisted Survivor Screening (CASS) as a routine screening measure for the survivor population. Specifically, to determine patient acceptance, time to completion, and burden associated with the CASS. To examine the potential utility of the CASS as a routine screening measure in the survivor population. To validate the CASS against the SCL-90-R screening measure. Calculate the sensitivity,specificity, positive and negative predictive values, diagnostic agreement and ROC curve of the CASS compared to the SCL-90. Determine the optimal cut-off scores to optimize agreement between the CASS and the SCL-90.

Enrollment: 100 estimated patients

Sex: All

Ages: 18 to 49 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Currently at least 18 years of age and not older than 49 years of age
• Diagnosed with first malignancy before the age of 22
• Completed all cancer treatment at least three years prior
• Able to complete the survey instruments in English
• Scheduled for a routine off-treatment follow-up oncology appointment
• Currently disease-free and not receiving any cancer treatment

Exclusion criteria

• History of a central nervous system tumor
• A sensory or cognitive impairment that would interfere with completion of the survey
• Currently undergoing treatment by a psychiatrist or psychologist (ie., currently receiving psychotherapy and/or psychotropic medications, as per self-report)